유럽의 주사기 및 바늘 시장

※ 본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

유럽의 주사기(Syringe) 및 바늘(Niddle) 시장을 조사 분석했으며, 질환 개요, 제품 평가, 국가별 개요, 시장 분석과 예측, 시장 성장 촉진요인 및 저해요인, 경쟁 분석 등의 정보를 전해드립니다.

제1장 조사 방법

제2장 질환 개요

• 기본 구조
  • 인체의 혈관계
• 혈관병변과 질환
  • 암
  • 말기 신부전
  • 당뇨병

제3장 제품 평가

• 제품 포트폴리오
  • 주사기 및 바늘
• 규제상 문제와 리콜
• 임상시험
• 제품 파이프라인

제4장 국가별 개요

• 서론
• 독일
• 프랑스
• 영국
• 이탈리아
• 스페인
• 베네룩스 국가
• 북유럽 국가
• 오스트리아
• 스위스
• 포르투갈

제5장 주사기 및 바늘 시장

• 서론
• 시장 개요
• 시장 분석과 예측
• 시장 성장 촉진요인 및 저해요인
  • 시장 성장 촉진요인
  • 시장 성장 저해요인
• 경쟁 시장 점유율 분석

약어

부록

The total market comprises two segments: syringes and needles. The syringe segment includes three sub-segments: conventional syringes, safety syringes and insulin syringes. The conventional syringe sub-segment includes two-part and three-part conventional syringes. The insulin syringe sub-segment includes insulin syringes sold with a needle and insulin syringes sold without a needle. The needle sub-segment includes three sub-segments: conventional needles, safety needles and blunt type needles. The majority of syringes and needles in Europe are sold separately and combined when used, but there are some unique markets such as Italy where high sales of syringes and needles already attached make the stand-alone market small by comparison.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

• 1.1. RESEARCH SCOPE
• 1.2. IDATA'S 9-STEP METHODOLOGY
  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

• 2.1. BASIC ANATOMY
  • 2.1.1. Human Vascular System
• 2.2. VASCULAR PATHOLOGY AND DISORDERS
  • 2.2.1. Cancer
  • 2.2.2. End-Stage Renal Disease
  • 2.2.3. Diabetes

PRODUCT ASSESSMENT

• 3.1. PRODUCT PORTFOLIOS
  • 3.1.1. Syringe and Needles
    • 3.1.1.1. Introduction
    • 3.1.1.2. Allison Medical
    • 3.1.1.2.1. SureComfort™
    • 3.1.1.3. B. Braun
    • 3.1.1.3.1. Injekt®
    • 3.1.1.3.2. Other Syringe & Needle Offerings
    • 3.1.1.4. Becton Dickinson
    • 3.1.1.4.1. BD™ Insulin Syringes
    • 3.1.1.4.2. BD™ Allergy Syringes
    • 3.1.1.4.3. BD™ Tuberculin Syringes
    • 3.1.1.4.4. BD™ Syringes & Needles
    • 3.1.1.4.5. BD PrecisionGlide™ Needles
    • 3.1.1.4.6. BD Safety-Lok™ Syringes
    • 3.1.1.4.7. BD SafetyGlide™ Syringes & Needles
    • 3.1.1.4.8. BD Eclipse™ Needles and Syringes
    • 3.1.1.4.9. BD Integra™ Needles and Syringes
    • 3.1.1.4.10. BD AutoShield™
    • 3.1.1.4.11. Ultra-Fine™
    • 3.1.1.5. Cardinal Health
    • 3.1.1.5.1. Cardinal Health™
    • 3.1.1.6. Delta Hi-Tech, Inc.
    • 3.1.1.6.1. AIMSCO®
    • 3.1.1.7. Medical Plastic Devices, Inc.
    • 3.1.1.7.1. Insupen®
    • 3.1.1.8. Medtronic
    • 3.1.1.8.1. Magellan™
    • 3.1.1.8.2. Monoject™
    • 3.1.1.9. MYCO Medical
    • 3.1.1.9.1. Dispovan®
    • 3.1.1.10. Nipro Medical
    • 3.1.1.10.1. Nipro™
    • 3.1.1.11. Novo Nordisk
    • 3.1.1.11.1. NovoFine®
    • 3.1.1.11.2. NovoTwist®
    • 3.1.1.12. Owen Mumford, Inc.
    • 3.1.1.12.1. Unifine®
    • 3.1.1.13. Perrigo
    • 3.1.1.13.1. Clickfine®
    • 3.1.1.14. Protectus Medical Devices
    • 3.1.1.14.1. Protectus®
    • 3.1.1.15. ReliOn
    • 3.1.1.15.1. ReliOn®
    • 3.1.1.16. Retractable Technologies, Inc.
    • 3.1.1.16.1. VanishPoint®
    • 3.1.1.16.2. Patient Safe®
    • 3.1.1.17. Revolutions Medical
    • 3.1.1.17.1. ReVac™
    • 3.1.1.18. Safety 1st Medical
    • 3.1.1.18.1. Safe-1®
    • 3.1.1.19. Smiths Medical
    • 3.1.1.19.1. Needle-Pro®
    • 3.1.1.20. SOL-MILLENNIUM
    • 3.1.1.20.1. SOL-CARE®
    • 3.1.1.20.2. SOL-M™
    • 3.1.1.20.3. SOL-GUARD™
    • 3.1.1.21. STAT Medical Devices
    • 3.1.1.21.1. Super-Fine™
    • 3.1.1.22. Terumo
    • 3.1.1.22.1. SurGuard®
    • 3.1.1.22.2. TERUMO®
    • 3.1.1.23. UltiCare
    • 3.1.1.23.1. UltiCare®
• 3.2. REGULATORY ISSUES AND RECALLS
  • 3.2.1. November 2015
  • 3.2.2. October 2015
  • 3.2.3. September 2015
  • 3.2.4. August 2015
  • 3.2.5. July 2015
  • 3.2.6. April 2015
  • 3.2.7. March 2015
  • 3.2.8. February 2015
  • 3.2.9. January 2015
  • 3.2.10. December 2014
  • 3.2.11. October 2014
  • 3.2.12. September 2014
  • 3.2.13. May 2014
  • 3.2.14. April 2014
  • 3.2.15. March 2014
  • 3.2.16. January 2014
  • 3.2.17. December 2013
  • 3.2.18. September 2013
  • 3.2.19. August 2013
  • 3.2.20. June 2013
  • 3.2.21. March 2013
  • 3.2.22. February 2013
  • 3.2.23. December 2012
  • 3.2.24. August 2012
  • 3.2.25. June 2012
  • 3.2.26. May 2012
  • 3.2.27. March 2012
  • 3.2.28. February 2012
  • 3.2.29. January 2012
• 3.3. CLINICAL TRIALS
  • 3.3.1. Syringe and Needles
• 3.4. PRODUCT PIPELINES
  • 3.4.1. Alliance Vascular Devices, LLC
    • 3.4.1.1. FreeHand Safety Huber Needle®
  • 3.4.2. AngioDynamics
    • 3.4.2.1. Celerity™ PICC Tip Confirmation System with Navigation
    • 3.4.2.2. Firefly
    • 3.4.2.3. BioFlo® PICC Line Extension
    • 3.4.2.4. BioFlo® Port Line Extension
    • 3.4.2.5. Next Generation BioFlo® PICC
    • 3.4.2.6. Next Generation BioFlo® Port
  • 3.4.3. Bluegrass Vascular Technologies, Inc.
    • 3.4.3.1. Surfacer® Inside-Out™ Access System
  • 3.4.4. C.R. Bard
    • 3.4.4.1. Chemical-Resistant PICCs
    • 3.4.4.2. Novel Advanced Material PICCs
    • 3.4.4.3. PowerGlide® Pro Midline
    • 3.4.4.4. AccuCath®
    • 3.4.4.5. Xenesis™ Acute Hemodialysis Catheter
    • 3.4.4.6. Site~Rite® 8 Ultrasound System
  • 3.4.5. M. C. Johnson
    • 3.4.5.1. PICC Securement Device
  • 3.4.6. Nipro Medical
    • 3.4.6.1. Shielding Safety Needle
    • 3.4.6.2. Safety Syringe
    • 3.4.6.3. Safety PIVC
  • 3.4.7. Parasol Medical
    • 3.4.7.1. Catheter Securement Device
  • 3.4.8. PAVmed Inc.
    • 3.4.8.1. NextCath™
  • 3.4.9. Phase One Medical
    • 3.4.9.1. Goldilocks™ Long Term Hemodialysis Catheter
    • 3.4.9.2. Triple-Lumen Symetrex™ Hemodialysis Catheter
  • 3.4.10. Prodigy Diabetes Care, LLC.
    • 3.4.10.1. Insulin Pen Needles
  • 3.4.11. Sharklet Technologies, Inc.
    • 3.4.11.1. Sharklet™ Central Venous Catheter
  • 3.4.12. Starboard Medical
    • 3.4.12.1. Catheter Securement Devices
  • 3.4.13. Teleflex Medical
    • 3.4.13.1. Arrow® Endurance™ Extended Dwell Peripheral Catheter System
    • 3.4.13.2. Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports
  • 3.4.14. Vascular Access Technologies, Inc.
    • 3.4.14.1. SAFECVAD™

COUNTRY PROFILES

• 4.1. INTRODUCTION
  • 4.1.1. Population
  • 4.1.2. GDP Per Capita
  • 4.1.3. Price Index
• 4.2. GERMANY
• 4.3. FRANCE
• 4.4. UNITED KINGDOM
• 4.5. ITALY
• 4.6. SPAIN
• 4.7. BENELUX
• 4.8. SCANDINAVIA
• 4.9. AUSTRIA
• 4.10. SWITZERLAND
• 4.11. PORTUGAL

SYRINGE AND NEEDLE MARKET

• 5.1. INTRODUCTION
  • 5.1.1. Two-Part and Three-Part Syringes
  • 5.1.2. Safety Devices
  • 5.1.3. Insulin Syringes
• 5.2. MARKET OVERVIEW
• 5.3. MARKET ANALYSIS AND FORECAST
  • 5.3.1. Total Syringe and Needle Market
  • 5.3.2. Total Syringe Market
    • 5.3.2.1. Total Conventional Syringe Market
    • 5.3.2.1.1. Two-Part Conventional Syringe Market
    • 5.3.2.1.2. Three-Part Conventional Syringe Market
    • 5.3.2.2. Safety Syringe Market
    • 5.3.2.3. Total Insulin Syringe Market
    • 5.3.2.3.1. Insulin Syringe with Needle Market
    • 5.3.2.3.2. Insulin Syringe without Needle Market
  • 5.3.3. Total Needle Market
    • 5.3.3.1. Conventional Needle Market
    • 5.3.3.2. Safety Needle Market
    • 5.3.3.3. Blunt Type Needle Market
• 5.4. DRIVERS AND LIMITERS
  • 5.4.1. Market Drivers
  • 5.4.2. Market Limiters
• 5.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

APPENDIX: COMPANY PRESS RELEASES

LIST OF CHARTS

• Chart 1-1: Vascular Access Device and Accessories Market by Segment, Europe, 2013-2023
• Chart 1-2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023
• Chart 4-1: Country Profile, Germany, 2016
• Chart 4-2: Country Profile, France, 2016
• Chart 4-3: Country Profile, United Kingdom, 2016
• Chart 4-4: Country Profile, Italy, 2016
• Chart 4-5: Country Profile, Spain, 2016
• Chart 4-6: Country Profile, Benelux, 2016
• Chart 4-7: Country Profile, Scandinavia, 2016
• Chart 4-8: Country Profile, Austria, 2016
• Chart 4-9: Country Profile, Switzerland, 2016
• Chart 4-10: Country Profile, Portugal, 2016
• Chart 5-1: Syringe and Needle Market by Segment, Europe, 2013-2023
• Chart 5-2: Syringe and Needle Market by Segment, Europe, 2016
• Chart 5-3: Syringe and Needle Market by Segment, Europe, 2023
• Chart 5-4: Total Syringe and Needle Market, Europe, 2013-2023
• Chart 5-5: Total Conventional Syringe Market, Europe, 2013-2023
• Chart 5-6: Safety Syringe Market, Europe, 2013-2023
• Chart 5-7: Total Insulin Syringe Market, Europe, 2013-2023
• Chart 5-8: Conventional Needle Market, Europe, 2013-2023
• Chart 5-9: Safety Needle Market, Europe, 2013-2023
• Chart 5-10: Blunt Type Needle Market, Europe, 2013-2023
• Chart 5-11: Leading Competitors, Syringe and Needle Market, Europe, 2016

LIST OF FIGURES

• Figure 1-1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016(1 of 2)
• Figure 1-2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016(2 of 2)
• Figure 1-3: Companies Researched in this Report, Europe, 2016
• Figure 1-4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016
• Figure 1-5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013-2016
• Figure 1-6: Vascular Access Procedures Covered, Europe, 2016
• Figure 1-7: Vascular Access Device and Accessories Markets Covered, Europe, 2016(1 of 3)
• Figure 1-8: Vascular Access Device and Accessories Markets Covered, Europe, 2016(2 of 3)
• Figure 1-9: Vascular Access Device and Accessories Markets Covered, Europe, 2016(3 of 3)
• Figure 1-10: Key Report Updates
• Figure 1-11: Version History
• Figure 3-1: Class 2 Device Recall Medtronic
• Figure 3-2: Class 2 Device Recall Smiths Medical
• Figure 3-3: Class 2 Device Recall Arrow
• Figure 3-4: Class 2 Device Recall Arrow
• Figure 3-5: Class 2 Device Recall Covidien(Medtronic)
• Figure 3-6: Class 2 Device Recall Arrow
• Figure 3-7: Class 2 Device Recall Medline
• Figure 3-8: Class 2 Device Recall Arrow
• Figure 3-9: Class 2 Device Recall B. Braun
• Figure 3-10: Class 3 Device Recall Bard Access
• Figure 3-11: Class 2 Device Recall Covidien(Medtronic)
• Figure 3-12: Class 2 Device Recall Bard Access
• Figure 3-13: Class 2 Device Recall Bard Access
• Figure 3-14: Class 2 Device Recall Medcomp & AngioDynamics
• Figure 3-15: Class 2 Device Recall Bard Access
• Figure 3-16: Class 2 Device Recall Arrow
• Figure 3-17: Class 2 Device Recall Medcomp
• Figure 3-18: Class 2 Device Recall Arrow
• Figure 3-19: Class 2 Device Recall Arrow
• Figure 3-20: Class 2 Device Recall Smiths Medical
• Figure 3-21: Class 2 Device Recall PFM Medical
• Figure 3-22: Class 2 Device Recall PFM Medical
• Figure 3-23: Class 2 Device Recall Becton Dickinson
• Figure 3-24: Class 2 Device Recall Arrow
• Figure 3-25: Class 2 Device Recall Arrow
• Figure 3-26: Class 2 Device Recall Navilyst Medical
• Figure 3-27: Class 2 Device Recall Argon Medical
• Figure 3-28: Class 2 Device Recall Arrow
• Figure 3-29: Class 2 Device Recall Arrow
• Figure 3-30: Class 2 Device Recall Arrow
• Figure 3-31: Class 2 Device Recall Bard Access
• Figure 3-32: Class 2 Device Recall Navilyst Medical
• Figure 3-33: Class 2 Device Recall Bard Access
• Figure 3-34: Class 2 Device Recall Smiths Medical
• Figure 3-35: Class 2 Device Recall B. Braun
• Figure 3-36: Class 2 Device Recall Smiths Medical
• Figure 3-37: Class 2 Device Recall Access Scientific
• Figure 3-38: Class 2 Device Recall Covidien(Medtronic)
• Figure 3-39: Class 2 Device Recall Arrow
• Figure 3-40: Class 2 Device Recall Bard Access
• Figure 3-41: Class 2 Device Recall Becton Dickinson
• Figure 3-42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
• Figure 3-43: Class 2 Device Recall Bard Access
• Figure 3-44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
• Figure 3-45: Class 2 Device Recall Medcomp
• Figure 3-46: Class 2 Device Recall Becton Dickinson
• Figure 3-47: Class 3 Device Recall Bard Access
• Figure 3-48: Class 2 Device Recall Medcomp
• Figure 3-49: Class 1 Device Recall Arrow
• Figure 3-50: Class 2 Device Recall Arrow
• Figure 3-51: Class 2 Device Recall Vygon
• Figure 3-52: Class 2 Device Recall Covidien(Medtronic)
• Figure 3-53: Class 2 Device Recall Medcomp
• Figure 3-54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
• Figure 3-55: Class 2 Device Recall Christie Medical Holdings
• Figure 3-56: Class 3 Recall Bard Access
• Figure 3-57: Class 2 Device Recall AngioDynamics
• Figure 3-58: Class 2 Device Recall Becton Dickinson
• Figure 3-59: Class 2 Device Recall AngioDynamics
• Figure 3-60: Class 2 Device Recall AngioDynamics
• Figure 3-61: Class 3 Device Recall AngioDynamics
• Figure 3-62: Class 2 Device Recall AngioDynamics
• Figure 3-63: A Randomized, Parallel Design Study
• Figure 3-64: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
• Figure 3-65: Transition From Parenteral Prostanoids to Inhaled Treprostinil
• Figure 3-66: Efficacy, Safety and Acceptability of the New Pen Needle
• Figure 3-67: A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity
• Figure 3-68: A Single Centre, Randomised, 3-period Cross-over Trial
• Figure 3-69: A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study
• Figure 3-70: Treating Diabetic Lipohypertrophy With Intensive Education
• Figure 3-71: Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin
• Figure 3-72: A Randomized, Multi-centre Cross-over Study
• Figure 3-73: A Clinical Investigation to Evaluate the Safety and Performance
• Figure 3-74: A Phase I, Randomized, Open-Label, Parallel-Group, Single-Dose, Multi-Center Study
• Figure 3-75: Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro
• Figure 3-76: Reproducibility of Insulin Action When Administered by Needle-free Jet Injection
• Figure 3-77: Patient Experiences With Injection Needles
• Figure 3-78: Inactivated Influenza Via Jet Injection
• Figure 3-79: Intradermal Rabies Immunization Using NanoJect: A Comparative Study
• Figure 3-80: Phase 1b, Partial-Blind, Parallel Group, Randomized Study
• Figure 3-81: A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity
• Figure 5-1: Syringe and Needle Market by Segment, Europe, 2013-2023(€M)
• Figure 5-2: Syringe and Needle Market by Segment, Europe, 2013-2023(US$M)
• Figure 5-3: Total Syringe and Needle Market, Europe, 2013-2023(€ and US$)
• Figure 5-4: Units Sold by Country, Total Syringe and Needle Market, Europe, 2013-2023
• Figure 5-5: Average Selling Price by Country, Total Syringe and Needle Market, Europe, 2013-2023(€)
• Figure 5-6: Average Selling Price by Country, Total Syringe and Needle Market, Europe, 2013-2023(US$)
• Figure 5-7: Market Value by Country, Total Syringe and Needle Market, Europe, 2013-2023(€M)
• Figure 5-8: Market Value by Country, Total Syringe and Needle Market, Europe, 2013-2023(US$M)
• Figure 5-9: Total Syringe Market, Europe, 2013-2023,(€ and US$)
• Figure 5-10: Units Sold by Country, Total Syringe Market, Europe, 2013-2023
• Figure 5-11: Average Selling Price by Country, Total Syringe Market, Europe, 2013-2023(€)
• Figure 5-12: Average Selling Price by Country, Total Syringe Market, Europe, 2013-2023(US$)
• Figure 5-13: Market Value by Country, Total Syringe Market, Europe, 2013-2023(€M)
• Figure 5-14: Market Value by Country, Total Syringe Market, Europe, 2013-2023(US$M)
• Figure 5-15: Total Conventional Syringe Market, Europe, 2013-2023,(€ and US$)
• Figure 5-16: Units Sold by Country, Total Conventional Syringe Market, Europe, 2013-2023
• Figure 5-17: Average Selling Price by Country, Total Conventional Syringe Market, Europe, 2013-2023(€)
• Figure 5-18: Average Selling Price by Country, Total Conventional Syringe Market, Europe, 2013-2023(US$)
• Figure 5-19: Market Value by Country, Total Conventional Syringe Market, Europe, 2013-2023(€M)
• Figure 5-20: Market Value by Country, Total Conventional Syringe Market, Europe, 2013-2023(US$M)
• Figure 5-21: Two-Part Conventional Syringe Market, Europe, 2013-2023(€ and US$)
• Figure 5-22: Units Sold by Country, Two-Part Conventional Syringe Market, Europe, 2013-2023
• Figure 5-23: Average Selling Price by Country, Two-Part Conventional Syringe Market, Europe, 2013-2023(€)
• Figure 5-24: Average Selling Price by Country, Two-Part Conventional Syringe Market, Europe, 2013-2023(US$)
• Figure 5-25: Market Value by Country, Two-Part Conventional Syringe Market, Europe, 2013-2023(€M)
• Figure 5-26: Market Value by Country, Two-Part Conventional Syringe Market, Europe, 2013-2023(US$M)
• Figure 5-27: Three-Part Conventional Syringe Market, Europe, 2013-2023(€ and US$)
• Figure 5-28: Units Sold by Country, Three-Part Conventional Syringe Market, Europe, 2013-2023
• Figure 5-29: Average Selling Price by Country, Three-Part Conventional Syringe Market, Europe, 2013-2023(€)
• Figure 5-30: Average Selling Price by Country, Three-Part Conventional Syringe Market, Europe, 2013-2023(US$)
• Figure 5-31: Market Value by Country, Three-Part Conventional Syringe Market, Europe, 2013-2023(€M)
• Figure 5-32: Market Value by Country, Three-Part Conventional Syringe Market, Europe, 2013-2023(US$M)
• Figure 5-33: Safety Syringe Market, Europe, 2013-2023(€ and US$)
• Figure 5-34: Units Sold by Country, Safety Syringe Market, Europe, 2013-2023
• Figure 5-35: Average Selling Price by Country, Safety Syringe Market, Europe, 2013-2023(€)
• Figure 5-36: Average Selling Price by Country, Safety Syringe Market, Europe, 2013-2023(US$)
• Figure 5-37: Market Value by Country, Safety Syringe Market, Europe, 2013-2023(€M)
• Figure 5-38: Market Value by Country, Safety Syringe Market, Europe, 2013-2023(US$M)
• Figure 5-39: Total Insulin Syringe Market, Europe, 2013-2023(€ and US$)
• Figure 5-40: Units Sold by Country, Total Insulin Syringe Market, Europe, 2013-2023
• Figure 5-41: Average Selling Price by Country, Total Insulin Syringe Market, Europe, 2013-2023(€)
• Figure 5-42: Average Selling Price by Country, Total Insulin Syringe Market, Europe, 2013-2023(US$)
• Figure 5-43: Market Value by Country, Total Insulin Syringe Market, Europe, 2013-2023(€M)
• Figure 5-44: Market Value by Country, Total Insulin Syringe Market, Europe, 2013-2023(US$M)
• Figure 5-45: Insulin Syringe with Needle Market, Europe, 2013-2023(€ and US$)
• Figure 5-46: Insulin Syringe without Needle Market, Europe, 2013-2023(€ and US$)
• Figure 5-47: Total Needle Market, Europe, 2013-2023(€ and US$)
• Figure 5-48: Units Sold by Country, Total Needle Market, Europe, 2013-2023
• Figure 5-49: Average Selling Price by Country, Total Needle Market, Europe, 2013-2023(€)
• Figure 5-50: Average Selling Price by Country, Total Needle Market, Europe, 2013-2023(US$)
• Figure 5-51: Market Value by Country, Total Needle Market, Europe, 2013-2023(€M)
• Figure 5-52: Market Value by Country, Total Needle Market, Europe, 2013-2023(US$M)
• Figure 5-53: Conventional Needle Market, Europe, 2013-2023(€ and US$)
• Figure 5-54: Units Sold by Country, Conventional Needle Market, Europe, 2013-2023
• Figure 5-55: Average Selling Price by Country, Conventional Needle Market, Europe, 2013-2023(€)
• Figure 5-56: Average Selling Price by Country, Conventional Needle Market, Europe, 2013-2023(US$)
• Figure 5-57: Market Value by Country, Conventional Needle Market, Europe, 2013-2023(€M)
• Figure 5-58: Market Value by Country, Conventional Needle Market, Europe, 2013-2023(US$M)
• Figure 5-59: Safety Needle Market, Europe, 2013-2023(€ and US$)
• Figure 5-60: Units Sold by Country, Safety Needle Market, Europe, 2013-2023
• Figure 5-61: Average Selling Price by Country, Safety Needle Market, Europe, 2013-2023(€)
• Figure 5-62: Average Selling Price by Country, Safety Needle Market, Europe, 2013-2023(US$)
• Figure 5-63: Market Value by Country, Safety Needle Market, Europe, 2013-2023(€M)
• Figure 5-64: Market Value by Country, Safety Needle Market, Europe, 2013-2023(US$M)
• Figure 5-65: Blunt Type Needle Market, Europe, 2013-2023(€ and US$)
• Figure 5-66: Drivers and Limiters, Syringe and Needle Market, Europe, 2016
• Figure 5-67: Leading Competitors by Country, Syringe and Needle Market, Europe, 2016
• Figure 7-1: Press Release Summary